Navigation Links
Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results
Date:11/13/2009

> Operating expenses in the third quarter of 2009 were $446,106, down 30% from $637,324 in the third quarter of 2008. This decrease was primarily due to the reduction of provision for doubtful debts and reduced research and development costs.

Operating income was $2.4 million, or 59% of revenue, an increase of 114% from $1.1 million, or 46% of revenue, in the third quarter of 2008.

Net income was $2.0 million, or $0.08 per share (basic and diluted), compared to a net income of $865,524, or $0.04 per share (basic and diluted), in the third quarter of 2008.

Nine months Ended September 30, 2009 Results

Net revenue was $10.1 million in the quarter ended September 30, 2009, up 30% from $7.8 million in the quarter ended September 30, 2008. Gross profit margin was 71%, which remained relatively unchanged as compared to the same period in 2008.

Operating income was $6.0 million, or 59% of revenue. Net income was $5.1 million or $0.20 per basic and fully diluted share, up 48% from $3.4 million, or $0.14 per fully diluted share in the nine-month period of 2008.

Financial Condition

As of September 30, 2009, the Company had $230,539 in cash and cash equivalents. Kun Run generated $2.9 million in cash flow from operations in the first nine months of 2009, compared to $4.3 in the first nine months of 2008. Shareholders' equity stood at $24.0 million, with a debt to equity ratio of 0.55 at the end of September 30, 2009.

Mr. Ye Xiaoqun, Chief Executive Officer of Kun Run Biotechnology commented, "I am satisfied with our third quarter performance, as we achieved record revenue and solid profits. During the past nine months, Kun Run has demonstrated success in developing and commercializing peptide medicine in the China market and has built reputable brand awareness with superior quality. With the extra capacity added by the newly operated facility, we
'/>"/>

SOURCE Kun Run Biotechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer
2. Misonix Announces New Distribution Agreement for Saudi Arabia and Other Middle Eastern Countries
3. Milestone Scientific Announces Third Quarter 2009 Results
4. EF Johnson Technologies Announces Third Quarter Results
5. Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
6. LifeVantage Announces Unaudited First Quarter Fiscal 2010 Financial and Operating Results
7. Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel Syndrome
8. WIFH Atlanta Announces Breakthrough Technique in Laser Hair Removal for Ethnic Skin Types
9. Mithridion Announces Progress With Drugs for Alzheimers Disease and Schizophrenia
10. Biostar Pharmaceuticals, Inc. Announces Record Third Quarter 2009 Financial Results
11. Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... July 25, 2014  CVS Caremark Corporation (NYSE: ... on Tuesday, August 5, 2014, at 8:30 a.m. (EDT) ... 2014 financial results. An audio webcast of ... Investor Relations portion of the CVS Caremark website for ... http://info.cvscaremark.com/investors . This webcast will be archived and available ...
(Date:7/25/2014)... , July 25, 2014  The Chemistry, Food ... Ministry of Health approved the introduction of Telaprevir ... the cure rate from Hepatitis C, and it ... 1 virus. Telaprevir is available in ... Photo - http://www2.prnewswire.com.br/imgs/pub/2014-07-25/original/2026.jpg   ...
(Date:7/25/2014)... , July 25, 2014  Acsis Inc., ... protection and serialization solutions, has recently posted an ... that addresses current and future needs for companies, ... the old supply chain model no longer work ... technology, including the growth of mobile technology, machine ...
Breaking Medicine Technology:The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3Acsis Addresses Questions on the Modern Supply Chain 2
... WIRE)--Jun 19, 2007 - Javelin,Pharmaceuticals (AMEX: JAV) ... morphine) successfully met its,primary clinical endpoint, the ... over 0-24 hours postoperatively. In this first ... moderate-to-severe pain,after elective orthopedic surgery were given ...
... --,Nuvelo, Inc. today announced the publication of the ... rNAPc2,To Help Eliminate MACE)/TIMI 32 clinical trial (N=255) ... of Cardiology (JACC), demonstrating,that higher-dose (greater than or ... (rNAPc2) reduced the incidence,and duration of ischemia as ...
Cached Medicine Technology:Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 2Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 3Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 4Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in,Journal of American College of Cardiology 2Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in,Journal of American College of Cardiology 3Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in,Journal of American College of Cardiology 4
(Date:7/25/2014)... News) -- Although cervical cancers are declining in the ... papillomavirus (HPV) are increasing, a new study indicates. ... the tongue and tonsils have increased over the past ... 45, the Canadian researchers report. "The increases in ... and of anal cancer among younger women are disturbing, ...
(Date:7/25/2014)... 2014 The Europe Cyber Security report ... Europe with analysis and forecast of revenue. This market ... 2014 to $19.07 billion by 2019, at a CAGR ... the TOC of the Europe Cyber Security Market report ... It also provides a glimpse of the segmentation in ...
(Date:7/25/2014)... American Brain Tumor Association (ABTA) today unveiled branding of ... patient and family conference in Chicago. , “This is ... we – the first and now only national organization ... tumor research – extend our reach by engaging volunteers ... our materials and services into the hands of those ...
(Date:7/25/2014)... Chicago, IL (PRWEB) July 25, 2014 Today, ... brain tumor, and yet, when it comes to pinpointing causes ... “Right now, we don’t know who, we don’t know when, ... Elizabeth M. Wilson, MNA, president & CEO, American Brain Tumor ... why the American Brain Tumor Association funds research to pursue ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 According to ... Substrate Wafer, Devices, Applications, and Geography - Analysis & ... by substrate is expected to reach $3.01 Billion by ... Sapphire Technology Market for devices is expected to reach ... that includes an in-depth analysis of application and geography. ...
Breaking Medicine News(10 mins):Health News:Anal, Throat Cancers on the Rise Among Young Adults, Study Finds 2Health News:Europe Cyber Security Market is Expected to Reach $19 billion in 2019 - New Report by MicroMarket Monitor 2Health News:Europe Cyber Security Market is Expected to Reach $19 billion in 2019 - New Report by MicroMarket Monitor 3Health News:Europe Cyber Security Market is Expected to Reach $19 billion in 2019 - New Report by MicroMarket Monitor 4Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 2Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 3Health News:Brain Tumor Causes and Risk Factors Elude Scientists 2Health News:Brain Tumor Causes and Risk Factors Elude Scientists 3Health News:Brain Tumor Causes and Risk Factors Elude Scientists 4Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 5Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 6
... exposure causes genetic changes in breast cells , , THURSDAY, ... many plastic products used in households caused accelerated breast ... a condition that might predispose the animals to breast ... Butyl benzyl phthalate (BBP) is commonly used to soften ...
... occurrence in television shows and movies, but can watching it make ... Although research has shown ... there has been little direct neuroscientific support for this theory until ... Researchers at Columbia University Medical Centers Functional ...
... Program Sets Stage for Increased Visibility ... Among Shareholders and Investors, ... EMIS ) announced today that it has retained Adam,Friedman Associates, ... is a biopharmaceutical company that focuses on a,unique and improved ...
... Insmed Inc. (Nasdaq:,INSM), a developer of follow-on biologics and ... 5th Annual Global Follow-On Biologics,Conference on December 11, 2007 ... be held at the Hyatt Regency Hotel in Reston,Virginia, ... and will bring together corporate, regulatory, financial, and legal,experts ...
... SAN FRANCISCO, Calif., Dec. 6 Proteolix, Inc.,announced ... studies using,intravenous carfilzomib (PR-171) are to be presented ... Meeting in Atlanta, Georgia, December,8-10, 2007. Carfilzomib is ... for the treatment of multiple myeloma,lymphoma and solid ...
... SGX Pharmaceuticals, Inc.,(Nasdaq: SGXP ) announced today details of ... chronic myelogenous leukemia,(CML) at the upcoming American Society of Hematology,s ... 8th - 11th, 2007 in,Atlanta, Georgia., , The schedule ... Date: ...
Cached Medicine News:Health News:Common Household Chemical Could Raise Breast Cancer Risk 2Health News:Common Household Chemical Could Raise Breast Cancer Risk 3Health News:This is your brain on violent media 2Health News:Emisphere Names Adam Friedman Associates IR Agency of Record 2Health News:Emisphere Names Adam Friedman Associates IR Agency of Record 3Health News:Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference 2Health News:Proteolix Announces Clinical Results With Carfilzomib to be Reported at ASH 2007 Annual Meeting 2Health News:SGX Pharmaceuticals BCR-ABL Program to be Presented at the American Society of Hematology 49th Annual Meeting and Exposition 2Health News:SGX Pharmaceuticals BCR-ABL Program to be Presented at the American Society of Hematology 49th Annual Meeting and Exposition 3Health News:SGX Pharmaceuticals BCR-ABL Program to be Presented at the American Society of Hematology 49th Annual Meeting and Exposition 4
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
Medicine Products: